OptimizeRx CorporationOPRXNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank86
3Y CAGR+3.7%
5Y CAGR+16.9%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+3.7%/yr
vs +43.7%/yr prior
5Y CAGR
+16.9%/yr
Recent deceleration
Acceleration
-40.0pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$57.21M-21.7%
2024$73.08M+5.5%
2023$69.30M+35.2%
2022$51.26M+45.3%
2021$35.28M+34.4%
2020$26.24M+37.1%
2019$19.13M+59.1%
2018$12.03M+48.8%
2017$8.08M+37.7%
2016$5.87M-